Literature DB >> 10644338

The central proline of an internal viral fusion peptide serves two important roles.

S E Delos1, J M Gilbert, J M White.   

Abstract

The fusion peptide of the avian sarcoma/leukosis virus (ASLV) envelope protein (Env) is internal, near the N terminus of its transmembrane (TM) subunit. As for most internal viral fusion peptides, there is a proline near the center of this sequence. Robson-Garnier structure predictions of the ASLV fusion peptide and immediate surrounding sequences indicate a region of order (beta-sheet), a tight reverse turn containing the proline, and a second region of order (alpha-helix). Similar motifs (order, turn or loop, order) are predicted for other internal fusion peptides. In this study, we made and analyzed 12 Env proteins with substitutions for the central proline of the fusion peptide. Env proteins were expressed in 293T cells and in murine leukemia virus pseudotyped virions. We found the following. (i) All mutant Envs form trimers, but when the bulky hydrophobic residues phenylalanine or leucine are substituted for proline, trimerization is weakened. (ii) Surprisingly, the proline is required for maximal processing of the Env precursor into its surface and TM subunits; the amount of processing correlates linearly with the propensity of the substituted residue to be found in a reverse turn. (iii) Nonetheless, proteolytically processed forms of all Envs are preferentially incorporated into pseudotyped virions. (iv) All Envs bind receptor with affinity greater than or equal to wild-type affinity. (v) Residues that support high infectivity cluster with proline at intermediate hydrophobicity. Infectivity is not supported by mutant Envs in which charged residues are substituted for proline, nor is it supported by the trimerization-defective phenylalanine and leucine mutants. Our findings suggest that the central proline in the ASLV fusion peptide is important for the formation of the native (metastable) Env structure as well as for membrane interactions that lead to fusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644338      PMCID: PMC111643          DOI: 10.1128/jvi.74.4.1686-1693.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Structural basis for paramyxovirus-mediated membrane fusion.

Authors:  K A Baker; R E Dutch; R A Lamb; T S Jardetzky
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

Review 2.  Membrane fusion and the alphavirus life cycle.

Authors:  M Kielian
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

3.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

4.  Phosphatidylinositol-dependent membrane fusion induced by a putative fusogenic sequence of Ebola virus.

Authors:  M B Ruiz-Argüello; F M Goñi; F B Pereira; J L Nieva
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

Authors:  M A Whitt; P Zagouras; B Crise; J K Rose
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Mutational analysis of the putative fusion domain of Ebola virus glycoprotein.

Authors:  H Ito; S Watanabe; A Sanchez; M A Whitt; Y Kawaoka
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein.

Authors:  J M Gilbert; L D Hernandez; T Chernov-Rogan; J M White
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.

Authors:  J L Nieva; S Nir; A Muga; F M Goñi; J Wilschut
Journal:  Biochemistry       Date:  1994-03-22       Impact factor: 3.162

9.  Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.

Authors:  M J Gething; R W Doms; D York; J White
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

10.  Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.

Authors:  L D Hernandez; R J Peters; S E Delos; J A Young; D A Agard; J M White
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

View more
  30 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus.

Authors:  K Stiasny; S L Allison; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide.

Authors:  B Adam; L Lins; V Stroobant; A Thomas; R Brasseur
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Structural and functional properties of an unusual internal fusion peptide in a nonenveloped virus membrane fusion protein.

Authors:  Maya Shmulevitz; Raquel F Epand; Richard M Epand; Roy Duncan
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.

Authors:  Joanne York; Jody D Berry; Ute Ströher; Qunnu Li; Heinz Feldmann; Min Lu; Meg Trahey; Jack H Nunberg
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

6.  Features of a spatially constrained cystine loop in the p10 FAST protein ectodomain define a new class of viral fusion peptides.

Authors:  Christopher Barry; Tim Key; Rami Haddad; Roy Duncan
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 7.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

8.  A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.

Authors:  Heidi E Drummer; Irene Boo; Anne L Maerz; Pantelis Poumbourios
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.

Authors:  Deborah C Melder; Xueqian Yin; Sue E Delos; Mark J Federspiel
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

10.  A rapid point of care immunoswab assay for SARS-CoV detection.

Authors:  Sriram Kammila; Dipankar Das; Pravin K Bhatnagar; Hoon H Sunwoo; Gustavo Zayas-Zamora; Malcolm King; Mavanur R Suresh
Journal:  J Virol Methods       Date:  2008-07-11       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.